$8.53
-0.36-4.05%
At close: -
$8.51
-0.02-0.23%
After Hours: 4:06 PM EDT
Comments
Loading...
Amneal Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AMRX | Benzinga
Amneal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 2
EPS Estimate
$0.170
Quarterly Revenue Estimate
$690.49M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.79B
Analyze the earnings history of Amneal Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals | $0.14 | $0.17 | — | — | $659.19M | $690.49M | — | — | 05/02/2025 | Get Alert |
| AMRX | Amneal Pharmaceuticals | $0.14 | $0.15 | $0.12 | -20.00% | $616.98M | $708.07M | $730.52M | 3.17% | 02/28/2025 | Get Alert |
| AMRX | Amneal Pharmaceuticals | $0.19 | $0.13 | $0.16 | 23.08% | $620.04M | $696.80M | $702.47M | 0.81% | 11/08/2024 | Get Alert |
| AMRX | Amneal Pharmaceuticals | $0.19 | $0.14 | $0.16 | 14.29% | $599.05M | $658.14M | $701.78M | 6.63% | 08/09/2024 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.14 | 55.56% | — | $619.03M | $659.19M | 6.49% | 05/03/2024 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.14 | 55.56% | — | $634.23M | $616.98M | -2.72% | 03/01/2024 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.19 | 46.15% | — | $595.27M | $620.04M | 4.16% | 11/07/2023 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.19 | 90.00% | — | $562.49M | $599.05M | 6.50% | 08/04/2023 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.12 | 20.00% | — | $537.31M | $557.54M | 3.77% | 05/05/2023 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.21 | $0.23 | 9.52% | — | $579.91M | $609.76M | 5.15% | 03/02/2023 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.18 | $0.14 | -22.22% | — | $564.15M | $545.56M | -3.30% | 11/04/2022 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.19 | -5.00% | — | $536.34M | $559.36M | 4.29% | 08/05/2022 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.12 | -7.69% | — | $503.97M | $497.63M | -1.26% | 05/04/2022 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.18 | -10.00% | — | $537.35M | $536.90M | -0.08% | 03/02/2022 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.21 | 5.00% | — | $545.06M | $528.59M | -3.02% | 11/03/2021 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.19 | $0.25 | 31.58% | — | $523.25M | $535.08M | 2.26% | 08/09/2021 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.18 | $0.20 | 11.11% | — | $515.34M | $493.11M | -4.31% | 05/07/2021 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.14 | 7.69% | — | $507.02M | $510.03M | 0.59% | 02/26/2021 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.12 | $0.16 | 33.33% | — | $482.11M | $519.29M | 7.71% | 11/06/2020 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.13 | 30.00% | — | $458.44M | $464.66M | 1.36% | 08/06/2020 | Get Alert |
| AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.20 | 122.22% | — | $444.23M | $498.53M | 12.22% | 05/11/2020 | Get Alert |
Amneal Pharmaceuticals (AMRX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $0.12 | $0.15 | -20.0 % |
| Q3 | 2024-11-08 | $0.16 | $0.13 | 23.1 % |
| Q2 | 2024-08-09 | $0.16 | $0.14 | 14.3 % |
| Q1 | 2024-05-03 | $0.14 | $0.09 | 55.6 % |
Amneal Pharmaceuticals (AMRX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $730.52M | $708.07M | 3.17 % |
| Q3 | 2024-11-08 | $702.47M | $696.80M | 0.81 % |
| Q2 | 2024-08-09 | $701.78M | $658.14M | 6.63 % |
| Q1 | 2024-05-03 | $659.19M | $619.03M | 6.49 % |
FAQ
When is Amneal Pharmaceuticals (NASDAQ:AMRX) reporting earnings?
Amneal Pharmaceuticals (AMRX) is scheduled to report earnings on May 2, 2025. The last reported earnings were for reported on February 28, 2025 for Q4.
What were the latest earnings per share (EPS) for Amneal Pharmaceuticals (NASDAQ:AMRX)?
The Actual EPS was $0.12, which missed the estimate of $0.15.
What were Amneal Pharmaceuticals’s (NASDAQ:AMRX) revenues?
The Actual Revenue was $730.5M, which beat the estimate of $708.1M.
Browse earnings estimates, EPS, and revenue on all stocks.